The Most Surprising Avengers and Marvel Characters Not Announced for Doomsday
Despite five hours of streamed casting announcements, there are still several characters and actors fans are surprised won’t ...
Eli Lilly & Co. stock underperforms Wednesday when compared to competitors
This was the stock's second consecutive day of losses.
Large pharma M&A deals stalling amid volatile policies, Reuters reports
Top health care investment bankers say that large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here
According to Direxion CEO Douglas Yones, Eli Lilly and Palo Alto Networks are prime candidates for leveraged trading.
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
We are thrilled to welcome Michael to Avalo’s Board of Directors during this pivotal time in our Company’s growth,” said Dr. Garry Neil, CEO of Avalo Therapeutics. “Michael’s extensive experience in ...
Mounjaro: Here Is How Eli Lilly Shares Have Performed Since The Launch Its Own 'Ozempic'
Ozempic, the Danish pharma giant Novo Nordisk's anti-diabetic drug, has had everyone's attention over the past year. The ...